---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-018397"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T10:17:24.818741+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Precision BioSciences hosts KOL event for PBGENE-DMD DMD program; no new data disclosed

## Summary
- KOL event on March 17, 2026 features Dr. Veerapandiyan and Pat Furlong discussing DMD unmet need and treatment landscape.
- Overview of PBGENE-DMD gene editing program and FUNCTION-DMD Phase 1/2 trial presented; no new clinical or financial data released.
- Presentation materials and webcast replay available on Precision BioSciences investor website.

## SEC filing metadata
- accession: 0001628280-26-018397
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000162828026018397/0001628280-26-018397-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000162828026018397/dtil-20260317.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-018397
- JSON: https://secwatch.observer/filing/0001628280-26-018397.json
- Plain text: https://secwatch.observer/filing/0001628280-26-018397.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.